The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $140.63

Today's change+5.90 +4.38%
Updated November 26 12:00 PM EST. Delayed by at least 15 minutes.
 

Becton Dickinson and Co

NYSE: BDX
Last

(U.S.) $140.63

Today's change+5.90 +4.38%
Updated November 26 12:00 PM EST. Delayed by at least 15 minutes.

Becton Dickinson and Co Hits New 100-day High

Becton Dickinson and Co is up sharply today, rallying (U.S.)$5.90 or 4.38% to (U.S.)$140.63 and setting a new 100-day high. Over the last five days, shares have gained 8.09% and 27.28% year to date. Shares have outperformed the S&P 500 by 14.39% during the last year.

Key company metrics

  • Open(U.S.) $136.85
  • Previous close(U.S.) $134.73
  • High(U.S.) $141.17
  • Low(U.S.) $136.79
  • Bid / Ask(U.S.) $140.59 / (U.S.) $140.63
  • YTD % change+27.28%
  • Volume1,335,205
  • Average volume (10-day)1,071,411
  • Average volume (1-month)1,075,509
  • Average volume (3-month)1,490,658
  • 52-week range(U.S.) $104.94 to (U.S.) $141.17
  • Beta0.87
  • Trailing P/E23.41×
  • P/E 1 year forward19.82×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $2.18
  • Dividend yield1.55%
  • Trailing EPS(U.S.) $6.01
Updated November 26 12:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+14.02%

Based on its net profit margin of 14.02%, Becton Dickinson and Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.20%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue2,2022,1572,0722,014
Total other revenue--------
Total revenue2,2022,1572,0722,014
Gross profit1,1031,1111,0531,034
Total cost of revenue1,0991,0461,019980
Total operating expense1,8011,7121,6911,636
Selling / general / administrative561528525531
Research & development140137147126
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total110-1
Operating income401445381378
Interest income (expense), net non-operating-36-33-33-34
Gain (loss) on sale of assets--------
Other--------
Income before tax376423363359
Income after tax300326287271
Income tax, total76977688
Net income300326287271
Total adjustments to net income1------
Net income before extra. items300326287271
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items301326287271
Inc. avail. to common incl. extra. items301326287271
Diluted net income301326287271
Dilution adjustment--------
Diluted weighted average shares196197197198
Diluted EPS excluding extraordinary itemsvalue per share1.531.651.451.37
Dividends per sharevalue per share0.550.550.550.55
Diluted normalized EPSvalue per share1.531.651.451.37